Sagility acquires CareSeed to accelerate AI-led quality operations and Medicare Advantage performance transformation
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 11 Jun 2026, 08:54 PM IST · BSE ID: 803d64dc-d12b-4165-8fdc-bf9b6e714c99
View Original BSE Filing (PDF)
💡
In Simple Terms
Sagility bought CareSeed, a healthcare analytics firm, to improve its AI-powered services for health plans.
🤖 AI Summary
- Sagility acquired CareSeed, a U.S.-based healthcare analytics company, to strengthen AI-led quality operations.
- CareSeed specializes in NCQA-certified HEDIS quality reporting, medical record review, and regulatory analytics.
- CareSeed serves 30 small and mid-sized U.S. payers, with a strong presence in Medicare Advantage.
- CareSeed reported revenues of $5.1 M and EBITDA of $1.6 M in CY25.
- The acquisition is expected to be EPS accretive and expand Sagility's market reach.
🔢 Key Numbers — exact figures from BSE filing, not rounded
CareSeed Revenues (CY25)
$5.1 M
CareSeed EBITDA (CY25)
$1.6 M
CareSeed EBITDA Margin (CY25)
31.4%
🏢 How This Affects the Company
This acquisition expands Sagility’s healthcare quality, HEDIS, and care gap orchestration capabilities, particularly strengthening its position in the Medicare Advantage market. It adds 28 new client relationships to Sagility’s portfolio.
The acquisition of CareSeed is expected to be EPS accretive for Sagility. CareSeed itself reported revenues of $5.1 M and EBITDA of $1.6 M in CY25.
Sagility will integrate CareSeed’s cloud-native platforms, Forecast and Harvest, to deliver an end-to-end quality operations continuum. This combines Sagility’s existing clinical and AI capabilities with CareSeed's specialized quality analytics.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this acquisition announcement.
👤
Who Is Affected
Shareholders of Sagility Ltd may benefit from the expected EPS accretive nature of the acquisition and the expansion of the company's business capabilities in healthcare analytics.
🔍
Management Signal
This acquisition signals management's intent to strategically expand Sagility’s healthcare quality and Stars capabilities and accelerate its transformation into a tech & AI-led quality operations partner.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarterly results — evaluate impact on Sagility's overall financial performance.
Sagility's integration updates — monitor successful incorporation of CareSeed's platforms.
Client base growth — observe expansion in Sagility's mid-market payer segment.
LOW RISK
The filing reports a profitable acquired entity and strategic expansion, presenting low immediate risk.
💡 Investor Takeaway
Sagility's acquisition of CareSeed, a healthcare analytics firm with $5.1 M revenues and $1.6 M EBITDA in CY25, enhances its AI-led quality operations and expands its Medicare Advantage market footprint. This move strengthens Sagility's service portfolio and client base.
⚖️ Strengths & Concerns
✅ Positives
- CareSeed reported revenues of $5.1 M and EBITDA of $1.6 M in CY25, indicating a profitable target for Sagility.
- The acquisition strengthens Sagility’s presence in the Medicare Advantage market and adds 28 new small and mid-sized health plan client relationships.
📅 Company Track Record
A previous filing on June 11, 2026, also noted Sagility's acquisition of CareSeed for up to US$ 30 M, aiming to bolster healthcare analytics capabilities. Sagility Limited (formerly Sagility India Limited) was incorporated on November 16, 2021, and listed on BSE on March 27, 2024. Limited public track record is available.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What company did Sagility acquire?
Sagility acquired CareSeed, a U.S.-based healthcare analytics company specializing in NCQA-certified HEDIS quality reporting.
What were CareSeed's revenues and EBITDA in CY25?
CareSeed reported revenues of $5.1 M and EBITDA of $1.6 M in Calendar Year 2025, with an EBITDA margin of 31.4%.
How many clients does CareSeed serve?
CareSeed serves 30 small and mid-sized U.S. payers, with a strong footprint in Medicare Advantage.
What is the primary objective of Sagility acquiring CareSeed?
The acquisition aims to accelerate Sagility’s AI-led quality operations and Medicare Advantage performance transformation, expanding its healthcare quality and Stars capabilities.
Questions based on this BSE filing only. For information purposes.